Qi Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Qi Zhang has a total of 209 co-authors. Here are the top co-authors by number of shared publications:
Wei Ding
State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology
42 shared publicationsXinjian Ji
Department of Chemistry Fudan University Shanghai 200433 China
32 shared publicationsTianlu Mo
Univ Shanghai Sci & Technol, Sch Hlth Sci & Engn, Shanghai 200093, Peoples R China
22 shared publicationsZixin Deng
State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University
21 shared publicationsDhanaraju Mandalapu
Department of Chemistry, Fudan University, Shanghai, 200433, China
14 shared publicationsSuze Ma
14 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (11) , 2109-2123
Beyond native reactivity: radical SAM enzymes as platforms for new-to-nature chemistry
Radical SAM enzymes are emerging as versatile platforms for new-to-nature chemistry. Photochemical activation, SAM analogues, and enzyme engineering expand their reactivity and biocatalytic potential.
- 4 November 2026
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (11) , 2109-2123
Open AccessBeyond native reactivity: radical SAM enzymes as platforms for new-to-nature chemistry
Radical SAM enzymes are emerging as versatile platforms for new-to-nature chemistry. Photochemical activation, SAM analogues, and enzyme engineering expand their reactivity and biocatalytic potential.
- Open Access
- 8 September 2026
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (9) , 5433-5438
A Protecting-Group-Free S-Glycosylation Strategy for Complex S-Glycopeptide Synthesis
Protecting-group (PG)-free S-glycosylation offers an attractive strategy for glycopeptide synthesis, yet practical methods for complex peptides remain limited. Here, we report a non-photochemical S-glycosylation strategy that directly couples unprotected glycosyl donors with unprotected cysteine-containing peptides, enabling efficient access to β-S-glycopeptides. The method shows broad compatibility with glycosyl donors and peptide substrates and enables direct glycosylation of a structurally complex 37-mer precursor bearing one free cysteine, four protected cysteines, and oxidation-sensitive functionalities, thereby facilitating the efficient synthesis of sublancin and diverse glycosylated analogues. In contrast to photochemical radical-based S-glycosylation, which produces α-S-glycopeptides and proved unsuitable for the full-length substrate, the present strategy allows efficient late-stage glycosylation of structurally complex peptides. Combined with a fragment-based native chemical ligation approach for α-S-glycoside synthesis, this platform provides stereochemically defined sublancin analogues and reveals that the configuration of the S-glycosidic linkage strongly influences antibacterial activity. These results establish a practical PG-free platform for complex S-glycopeptide synthesis and glycocin structure–activity studies.
- 8 September 2026
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (9) , 5433-5438
Open AccessA Protecting-Group-Free S-Glycosylation Strategy for Complex S-Glycopeptide Synthesis
Protecting-group (PG)-free S-glycosylation offers an attractive strategy for glycopeptide synthesis, yet practical methods for complex peptides remain limited. Here, we report a non-photochemical S-glycosylation strategy that directly couples unprotected glycosyl donors with unprotected cysteine-containing peptides, enabling efficient access to β-S-glycopeptides. The method shows broad compatibility with glycosyl donors and peptide substrates and enables direct glycosylation of a structurally complex 37-mer precursor bearing one free cysteine, four protected cysteines, and oxidation-sensitive functionalities, thereby facilitating the efficient synthesis of sublancin and diverse glycosylated analogues. In contrast to photochemical radical-based S-glycosylation, which produces α-S-glycopeptides and proved unsuitable for the full-length substrate, the present strategy allows efficient late-stage glycosylation of structurally complex peptides. Combined with a fragment-based native chemical ligation approach for α-S-glycoside synthesis, this platform provides stereochemically defined sublancin analogues and reveals that the configuration of the S-glycosidic linkage strongly influences antibacterial activity. These results establish a practical PG-free platform for complex S-glycopeptide synthesis and glycocin structure–activity studies.
- 2 September 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (37) , 11673-11677
A Second-Shell Mutation Preorganizes HpnG for Broad-Scope Nucleoside Transglycosylation
Nucleoside analogues are important therapeutic scaffolds, but their synthesis is often protecting-group-intensive. Purine nucleoside phosphorylases offer a mild enzymatic alternative, yet broad substrate accommodation does not necessarily lead to productive glycosyl transfer. Here, we repurposed HpnG, a hopanoid-associated purine nucleoside phosphorylase, through second-shell engineering. Structure-guided substitution of D124 with glycine increased 2-fluoroadenosine formation from 11% to 91% yield and accelerated inosine phosphorolysis by more than 100-fold with little change in the apparent Km for inosine. HpnG-D124G also accepted diverse purine nucleobases and ribose, 2′-deoxyribose, and arabinose donors, enabling access to drug-relevant nucleosides. Molecular dynamics simulations and electronic-structure calculations suggest that D124G enriches donor–acceptor conformations that are properly aligned for glycosyl transfer. These findings establish productive active-site preorganization as a practical strategy for engineering broad-scope nucleoside biocatalysts.
- 2 September 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (37) , 11673-11677
A Second-Shell Mutation Preorganizes HpnG for Broad-Scope Nucleoside Transglycosylation
Nucleoside analogues are important therapeutic scaffolds, but their synthesis is often protecting-group-intensive. Purine nucleoside phosphorylases offer a mild enzymatic alternative, yet broad substrate accommodation does not necessarily lead to productive glycosyl transfer. Here, we repurposed HpnG, a hopanoid-associated purine nucleoside phosphorylase, through second-shell engineering. Structure-guided substitution of D124 with glycine increased 2-fluoroadenosine formation from 11% to 91% yield and accelerated inosine phosphorolysis by more than 100-fold with little change in the apparent Km for inosine. HpnG-D124G also accepted diverse purine nucleobases and ribose, 2′-deoxyribose, and arabinose donors, enabling access to drug-relevant nucleosides. Molecular dynamics simulations and electronic-structure calculations suggest that D124G enriches donor–acceptor conformations that are properly aligned for glycosyl transfer. These findings establish productive active-site preorganization as a practical strategy for engineering broad-scope nucleoside biocatalysts.
- Open Access
- 5 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (32)
An N-acetylated daropeptide modulates nematode development
The symbiotic bacterium Photorhabdus is a rich source of bioactive secondary metabolites that mediate tripartite interactions with nematodes and insect hosts. However, natural products of ribosomal origin remain largely underexplored within this ecological niche. Here, we report the identification of aphotorhaptin A, a darobactin-like peptide (daropeptide) natural product from Photorhabdus asymbiotica , which structurally features an ether crosslink and an N-terminal acetyl unit. Biosynthetic investigation uncovers aphotorhaptin A is matured via an unexpected leader cleavage step, and the subsequent N-terminal acetylation confers metabolic stability that maintains the hexapeptide scaffold integrity. Biochemical and structural studies demonstrate the acetyltransferase PasC exhibits remarkable substrate promiscuity, facilitated by an expansive active-site cavity that accommodates diverse acyl-CoA donors and peptide substrates. Unlike the antimicrobial darobactin, aphotorhaptin A appears to lack antibacterial activity but modulates nematode development, and this activity requires the ether crosslink and the N-terminal acetyl group in the hexapeptide scaffold. These findings expand the chemical and biosynthetic space of ribosomal peptide family and establish its link with nematode development and reproduction.
- 5 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (32)
Open AccessAn N-acetylated daropeptide modulates nematode development
The symbiotic bacterium Photorhabdus is a rich source of bioactive secondary metabolites that mediate tripartite interactions with nematodes and insect hosts. However, natural products of ribosomal origin remain largely underexplored within this ecological niche. Here, we report the identification of aphotorhaptin A, a darobactin-like peptide (daropeptide) natural product from Photorhabdus asymbiotica , which structurally features an ether crosslink and an N-terminal acetyl unit. Biosynthetic investigation uncovers aphotorhaptin A is matured via an unexpected leader cleavage step, and the subsequent N-terminal acetylation confers metabolic stability that maintains the hexapeptide scaffold integrity. Biochemical and structural studies demonstrate the acetyltransferase PasC exhibits remarkable substrate promiscuity, facilitated by an expansive active-site cavity that accommodates diverse acyl-CoA donors and peptide substrates. Unlike the antimicrobial darobactin, aphotorhaptin A appears to lack antibacterial activity but modulates nematode development, and this activity requires the ether crosslink and the N-terminal acetyl group in the hexapeptide scaffold. These findings expand the chemical and biosynthetic space of ribosomal peptide family and establish its link with nematode development and reproduction.
- Open Access
- 23 May 2026
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (6) , 3405-3413
Sulfation in the Biosynthesis of the Heptadecaglycoside Antibiotic Saccharomicin A
Sulfation is a ubiquitous modification in glycobiology, yet its enzymology and biological significance in glycosylated natural products remain poorly understood. Saccharomicin A, a potent oligosaccharide antibiotic, carries 17 sugars including a unique sulfated fucose. Here, we report the identification of Sam10 as an unprecedented fucose-specific sulfotransferase through genetic studies, in vitro reconstitution, and structural analysis, establishing its role in saccharomicin sulfation. Comparative bioassays revealed that sulfation contributes to antibacterial potency, including activity against diverse multidrug-resistant pathogens. We also characterized Sam35 as an efficient adenylyl-sulfate kinase that boosts cellular 3′-phosphoadenosine-5′-phosphate sulfate (PAPS) supply. Our findings define the biochemical and structural basis of saccharomicin sulfation and provide enzymatic tools for engineering novel sulfated oligosaccharide antibiotics.
- 23 May 2026
- Published by American Chemical Society (ACS) in JACS Au
- Vol. 6 (6) , 3405-3413
Open AccessSulfation in the Biosynthesis of the Heptadecaglycoside Antibiotic Saccharomicin A
Sulfation is a ubiquitous modification in glycobiology, yet its enzymology and biological significance in glycosylated natural products remain poorly understood. Saccharomicin A, a potent oligosaccharide antibiotic, carries 17 sugars including a unique sulfated fucose. Here, we report the identification of Sam10 as an unprecedented fucose-specific sulfotransferase through genetic studies, in vitro reconstitution, and structural analysis, establishing its role in saccharomicin sulfation. Comparative bioassays revealed that sulfation contributes to antibacterial potency, including activity against diverse multidrug-resistant pathogens. We also characterized Sam35 as an efficient adenylyl-sulfate kinase that boosts cellular 3′-phosphoadenosine-5′-phosphate sulfate (PAPS) supply. Our findings define the biochemical and structural basis of saccharomicin sulfation and provide enzymatic tools for engineering novel sulfated oligosaccharide antibiotics.
- 7 May 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (19) , 14794-14813
Chemistry and Biology of Antifungal Cyclic Peptides
Confronting the escalating threat of drug-resistant invasive fungal infections, cyclic peptides have emerged as a privileged scaffold for next-generation antifungal discovery. Their cyclic architecture confers enhanced metabolic stability, the peptide backbone enables efficient synthetic access, and their modular nature permits systematic structural diversification. This review summarizes recent advances in both natural and synthetic antifungal cyclic peptides, highlighting their biological sources, mechanisms of action, and structure-activity relationships (SAR). By offering an integrated perspective on this evolving chemical class, this work aims to inform the rational design of novel antifungal agents capable of overcoming existing therapeutic limitations.
- 7 May 2026
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 74 (19) , 14794-14813
Chemistry and Biology of Antifungal Cyclic Peptides
Confronting the escalating threat of drug-resistant invasive fungal infections, cyclic peptides have emerged as a privileged scaffold for next-generation antifungal discovery. Their cyclic architecture confers enhanced metabolic stability, the peptide backbone enables efficient synthetic access, and their modular nature permits systematic structural diversification. This review summarizes recent advances in both natural and synthetic antifungal cyclic peptides, highlighting their biological sources, mechanisms of action, and structure-activity relationships (SAR). By offering an integrated perspective on this evolving chemical class, this work aims to inform the rational design of novel antifungal agents capable of overcoming existing therapeutic limitations.
- Open Access
- 11 February 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (7)
A ribosomally synthesized and posttranslationally modified peptide with ADP-ribosylation
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are a fertile ground for uncovering new enzymatic chemistry and structural complexity. Here, we describe minviopeptin, an unusual ADP-ribosylated triceptide accessed through heterologous expression of a cryptic biosynthetic gene cluster. Structural and functional analyses reveal a combination of crosslinking, ADP-ribosylation, and oxidative peptide cleavage, underscoring the capacity of RiPP pathways to generate densely functionalized molecular scaffolds. By revealing ADP-ribosylation as a previously unrecognized RiPP modification and exposing reactivity within radical SAM and nonheme iron enzymes, this work broadens the landscape of RiPP biosynthetic chemistries and offers opportunities for natural product diversification and peptide engineering.
- 11 February 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (7)
Open AccessA ribosomally synthesized and posttranslationally modified peptide with ADP-ribosylation
Ribosomally synthesized and posttranslationally modified peptides (RiPPs) are a fertile ground for uncovering new enzymatic chemistry and structural complexity. Here, we describe minviopeptin, an unusual ADP-ribosylated triceptide accessed through heterologous expression of a cryptic biosynthetic gene cluster. Structural and functional analyses reveal a combination of crosslinking, ADP-ribosylation, and oxidative peptide cleavage, underscoring the capacity of RiPP pathways to generate densely functionalized molecular scaffolds. By revealing ADP-ribosylation as a previously unrecognized RiPP modification and exposing reactivity within radical SAM and nonheme iron enzymes, this work broadens the landscape of RiPP biosynthetic chemistries and offers opportunities for natural product diversification and peptide engineering.
- 1 August 2025
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 42 (10) , 1676-1689
para -Quinone methides in natural product biosynthesis
This highlight focuses on nature's strategic use of highly reactive para -quinone methides ( p -QMs) as key intermediates in natural product biosynthesis.
- 1 August 2025
- Published by Royal Society of Chemistry (RSC) in Natural Product Reports
- Vol. 42 (10) , 1676-1689
para -Quinone methides in natural product biosynthesis
This highlight focuses on nature's strategic use of highly reactive para -quinone methides ( p -QMs) as key intermediates in natural product biosynthesis.
- 31 July 2025
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 15 (16) , 14108-14114
Light-Driven Reactions Catalyzed by Radical S-Adenosylmethionine Enzymes
- 31 July 2025
- Published by American Chemical Society (ACS) in ACS Catalysis
- Vol. 15 (16) , 14108-14114
Light-Driven Reactions Catalyzed by Radical S-Adenosylmethionine Enzymes
- 16 July 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (28) , 6694-6698
Production of subtilosin A in E. coli : insights into the head-to-tail macrocyclization
The metalloenzymes AlbE and Alb are both essential for forming the macrocyclic ring structure of subtilosin A, the canonical member of the sactipeptide family.
- 16 July 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (28) , 6694-6698
Production of subtilosin A in E. coli : insights into the head-to-tail macrocyclization
The metalloenzymes AlbE and Alb are both essential for forming the macrocyclic ring structure of subtilosin A, the canonical member of the sactipeptide family.